Fruzaqla

News

NICE relents on Takeda colorectal cancer drug Fruzaqla

Colorectal cancer patients could soon have access via the NHS to a targeted oral drug that can give them more precious time with their loved ones.

News

NICE turns down Takeda colorectal cancer drug

Takeda's recently approved advanced colorectal cancer therapy Fruzaqla has been rejected by NICE for use by the NHS on the grounds that it is not cost-effective.

News

Takeda bags FDA okay for Fruzaqla in colorectal cancer

The FDA has approved Takeda’s Fruzaqla for a group of patients with relapsed or refractory metastatic colorectal cancer, offering another option for patients who have exha

NICE relents on Takeda colorectal cancer drug Fruzaqla

NICE turns down Takeda colorectal cancer drug

Takeda bags FDA okay for Fruzaqla in colorectal cancer

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

Editor's Picks